Genscript USA INC

UEI KVLBRRAQ6UX1 · NJ · SAM.gov record ↗

$1.5M

FY2025 obligations

Contract awards

Jun 18, 2014

First action

May 27, 2026

Latest action

Obligations by agency

Department Of Health And Human Services$1.5M
Department Of Agriculture$-9K

Obligations by NAICS

Monthly obligations

Dec 24

Jan 25

Feb 25

May 25

Jul 25

Aug 25

Sep 25

Jan 26

Feb 26

Apr 26

May 26

Contracts ending within 18 months (recompete watch)

75N91024P00630 ↗$1.0M
SYNTHESIS SERVICES FOR CUSTOM BIOMOLECULES (GENE CONSTRUCTS AND PEPTIDES) IN SUPPORT OF NATIONAL INSTITUTES OF HEALTH (NIH), NATIONAL CANCER INSTITUTE (NCI), CENTER FOR CANCER RESEARCH (CCR), SURGERY BRANCH (SB)
Ends
Sep 22, 2026
Started
Sep 23, 2024
Agency
National Institutes Of Health
NAICS
621511

PIID	Description	Agency	NAICS	Obligated	Start	End
75N91024P00630 ↗	SYNTHESIS SERVICES FOR CUSTOM BIOMOLECULES (GENE CONSTRUCTS AND PEPTIDES) IN SUPPORT OF NATIONAL INSTITUTES OF HEALTH (NIH), NATIONAL CANCER INSTITUTE (NCI), CENTER FOR CANCER RESEARCH (CCR), SURGERY BRANCH (SB)	National Institutes Of Health	621511	$1.0M	Sep 23, 2024	Sep 22, 2026

Largest awards

75N91024P00630 ↗$1.0M
SYNTHESIS SERVICES FOR CUSTOM BIOMOLECULES (GENE CONSTRUCTS AND PEPTIDES) IN SUPPORT OF NATIONAL INSTITUTES OF HEALTH (NIH), NATIONAL CANCER INSTITUTE (NCI), CENTER FOR CANCER RESEARCH (CCR), SURGERY BRANCH (SB)
Ends
Sep 22, 2026
Started
Sep 23, 2024
Agency
National Institutes Of Health
NAICS
621511
75N93025P00999 ↗$165K
MONOCLONAL ANTIBODIES AND PLASMIDS SERVICES
Ends
Jun 14, 2026
Started
Jun 14, 2025
Agency
National Institutes Of Health
NAICS
541380
75N93025P00998 ↗$165K
MONOCLONAL ANTIBODIES AND PLASMIDS SERVICES
Ends
Jun 13, 2026
Started
Jun 14, 2025
Agency
National Institutes Of Health
NAICS
541380
75N93025P00238 ↗$137K
MONOCLONAL ANTIBODIES AND PLASMIDS SERVICES
Ends
Aug 30, 2025
Started
Jan 14, 2025
Agency
National Institutes Of Health
NAICS
541380
75N92025P00349 ↗$25K
[25-014527] NHLBI BBC OOTC REQUIRES PLASMID SYNTHESIS AND CLONING SERVICES IN ORDER TO EXPERIMENTALLY TEST PREDICTED PROTEIN STRUCTURES AS PART OF ONGOING RESEARCH PROJECTS
Ends
Aug 27, 2026
Started
Aug 28, 2025
Agency
National Institutes Of Health
NAICS
541380
75N92025P00334 ↗$25K
[25-014297] NHLBI PRAT IRTA FELLOW REQUIRES GENSCRIPT PO FOR GENE SYNTHESIS, SUB CLONING, AND PLASMID PREP IN ORDER TO CONTINUE WORK LOOKING INTO HOW RFAH EVOLVED INCLUDING IN VITRO AND IN SITU EXPERIMENTS
Ends
Aug 23, 2026
Started
Aug 24, 2025
Agency
National Institutes Of Health
NAICS
541380
75N90025P00611 ↗$25K
ANTIBODY FRAGMENT HUMANIZATION SERVICES GENSCRIPT USA INCORPORATED:1171214 [25-008847]
Ends
Sep 4, 2025
Started
Aug 5, 2025
Agency
National Institutes Of Health
NAICS
541714
75N95A25P00106 ↗$23K
THIS IS FOR CLINICAL RESEARCH STUDY CRISPR-BASED GENOME EDITING SERVICE TO GENERATE PC12 CELL LINES WITH SNAP AND HALO-TAG SINSERTED AT ENDOGENOUS LOCI OF VAMP2 AND SYNTAXIN1A. INCLUDES GUIDE RNA DESIGN, DONOR SYNTHESIS, TRANSFECTION, CLONAL SCREENIN
Ends
Feb 12, 2026
Started
Aug 13, 2025
Agency
National Institutes Of Health
NAICS
541690
75N93025P00284 ↗$22K
GENE SYNTHESIS AND CLONING SERVICES TO CONTINUE THE ANALYSIS OF PRECIOUS CLINICAL STUDY SAMPLES ALREADY IN PROGRESS IN RESEARCH ON RSV-ASSOCIATED ILLNESS AND PNEUMONIA
Ends
Apr 29, 2025
Started
Feb 18, 2025
Agency
National Institutes Of Health
NAICS
541380
75N98024A00139 ↗$0
O/M ITEMS ONLY: BLOOD AND BLOOD PRODUCTS AND BIOLOGICAL MATERIALS
Ends
—
Started
Jun 18, 2014
Agency
National Institutes Of Health
NAICS
541714
75F40124C00123 ↗$0
THIS REQUEST IS TO OBTAIN A CONTRACT WITH A BIOTECHNOLOGY SERVICE PROVIDER TO PERFORM A MONOCLONAL ANTIBODY (MOAB) DEVELOPMENT SERVICE
Ends
Sep 18, 2025
Started
Sep 9, 2024
Agency
Food And Drug Administration
NAICS
541720
75N94020P00373 ↗$-0
THIS AWARD IS HEREBY MODIFIED TO INCORPORATE HHSAR 352.232-71 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS IN FULL TEXT AND PROVIDE INSTRUCTIONS FOR THE TRANSITION FROM THE NIH OFFICE OF FINANCIAL MANAGEMENT (OFM) ELECTRONIC INVOICE SUBMISSION TO THE DE
Ends
May 16, 2021
Started
May 17, 2020
Agency
National Institutes Of Health
NAICS
541714
75F40120P00404 ↗$-0
MONOCLONAL ANTIBODY PRODUCTION
Ends
Jul 30, 2021
Started
Jul 20, 2020
Agency
Food And Drug Administration
NAICS
325414
75F40122P00418 ↗$-7
THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT.
Ends
Aug 29, 2023
Started
Aug 30, 2022
Agency
Food And Drug Administration
NAICS
325414
75N93022P01112 ↗$-22
FY26 UDO INITIATIVE GENE SYNTHESIS AND PROTEIN PRODUCTION (AMBIS #2136137)
Ends
Aug 31, 2023
Started
Aug 30, 2022
Agency
National Institutes Of Health
NAICS
541990
75N93022P00476 ↗$-30
FY26 UDO INITIATIVE SEQUENCING AND GENE SYNTHESIS SERVICE FOR 100 SAMPLES
Ends
Mar 15, 2023
Started
Mar 16, 2022
Agency
National Institutes Of Health
NAICS
541380
75N93021P00884 ↗$-30
TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.
Ends
Jul 1, 2021
Started
Jun 29, 2021
Agency
National Institutes Of Health
NAICS
325413
75N93020P00483 ↗$-31
LAW2018260 CUSTOMIZED DNA AND MONOCLONAL ANTIBODY PRODUCTION : QUOTE NO: U056VFC130
Ends
May 4, 2020
Started
Apr 6, 2020
Agency
National Institutes Of Health
NAICS
541714
75N93022P01145 ↗$-72
FY26 UDO INITIATIVE PEPTIDE SEQUENCING SERVICE
Ends
Oct 4, 2022
Started
Sep 4, 2022
Agency
National Institutes Of Health
NAICS
541380
75N91020F00001 ↗$-142
TO DE-OBLIGATE FY20 EXPIRING LINES PER NIH OALM COMMUNICATION 25-06 (20241105).
Ends
Jan 2, 2025
Started
Nov 17, 2019
Agency
National Institutes Of Health
NAICS
621991
75N93021P01351 ↗$-185
FY26 UDO INITIATIVE SEQUENCING SERVICES
Ends
Dec 30, 2021
Started
Sep 12, 2021
Agency
National Institutes Of Health
NAICS
541380
75N93023P01112 ↗$-195
FY26 UDO INITIATIVE: DNA SERVICES (GENE SYNTHESIS, VECTORARK CLONING, EXPRESS PLASMID PREPARATION) (AMBIS #2181581)
Ends
Nov 29, 2023
Started
Aug 22, 2023
Agency
National Institutes Of Health
NAICS
541380
75N93020P01044 ↗$-342
CUSTOMIZED DNA AND MONOCLONAL ANTIBODY PRODUCTION : QUOTE NO: U150TFF080
Ends
Sep 4, 2020
Started
Aug 5, 2020
Agency
National Institutes Of Health
NAICS
325413
75N93023P01326 ↗$-500
FY26 UDO INITIATIVE: CUSTOM GENE SYNTHESIS AND EXPRESSION
Ends
Dec 30, 2023
Started
Sep 17, 2023
Agency
National Institutes Of Health
NAICS
541380
75N93020P01205 ↗$-647
ANTIBODY GENE SYNTHESIS AND PRODUCTION
Ends
Feb 5, 2021
Started
Aug 25, 2020
Agency
National Institutes Of Health
NAICS
541990

PIID	Description	Agency	NAICS	Obligated	Start	End
75N91024P00630 ↗	SYNTHESIS SERVICES FOR CUSTOM BIOMOLECULES (GENE CONSTRUCTS AND PEPTIDES) IN SUPPORT OF NATIONAL INSTITUTES OF HEALTH (NIH), NATIONAL CANCER INSTITUTE (NCI), CENTER FOR CANCER RESEARCH (CCR), SURGERY BRANCH (SB)	National Institutes Of Health	621511	$1.0M	Sep 23, 2024	Sep 22, 2026
75N93025P00999 ↗	MONOCLONAL ANTIBODIES AND PLASMIDS SERVICES	National Institutes Of Health	541380	$165K	Jun 14, 2025	Jun 14, 2026
75N93025P00998 ↗	MONOCLONAL ANTIBODIES AND PLASMIDS SERVICES	National Institutes Of Health	541380	$165K	Jun 14, 2025	Jun 13, 2026
75N93025P00238 ↗	MONOCLONAL ANTIBODIES AND PLASMIDS SERVICES	National Institutes Of Health	541380	$137K	Jan 14, 2025	Aug 30, 2025
75N92025P00349 ↗	[25-014527] NHLBI BBC OOTC REQUIRES PLASMID SYNTHESIS AND CLONING SERVICES IN ORDER TO EXPERIMENTALLY TEST PREDICTED PROTEIN STRUCTURES AS PART OF ONGOING RESEARCH PROJECTS	National Institutes Of Health	541380	$25K	Aug 28, 2025	Aug 27, 2026
75N92025P00334 ↗	[25-014297] NHLBI PRAT IRTA FELLOW REQUIRES GENSCRIPT PO FOR GENE SYNTHESIS, SUB CLONING, AND PLASMID PREP IN ORDER TO CONTINUE WORK LOOKING INTO HOW RFAH EVOLVED INCLUDING IN VITRO AND IN SITU EXPERIMENTS	National Institutes Of Health	541380	$25K	Aug 24, 2025	Aug 23, 2026
75N90025P00611 ↗	ANTIBODY FRAGMENT HUMANIZATION SERVICES GENSCRIPT USA INCORPORATED:1171214 [25-008847]	National Institutes Of Health	541714	$25K	Aug 5, 2025	Sep 4, 2025
75N95A25P00106 ↗	THIS IS FOR CLINICAL RESEARCH STUDY CRISPR-BASED GENOME EDITING SERVICE TO GENERATE PC12 CELL LINES WITH SNAP AND HALO-TAG SINSERTED AT ENDOGENOUS LOCI OF VAMP2 AND SYNTAXIN1A. INCLUDES GUIDE RNA DESIGN, DONOR SYNTHESIS, TRANSFECTION, CLONAL SCREENIN	National Institutes Of Health	541690	$23K	Aug 13, 2025	Feb 12, 2026
75N93025P00284 ↗	GENE SYNTHESIS AND CLONING SERVICES TO CONTINUE THE ANALYSIS OF PRECIOUS CLINICAL STUDY SAMPLES ALREADY IN PROGRESS IN RESEARCH ON RSV-ASSOCIATED ILLNESS AND PNEUMONIA	National Institutes Of Health	541380	$22K	Feb 18, 2025	Apr 29, 2025
75N98024A00139 ↗	O/M ITEMS ONLY: BLOOD AND BLOOD PRODUCTS AND BIOLOGICAL MATERIALS	National Institutes Of Health	541714	$0	Jun 18, 2014	—
75F40124C00123 ↗	THIS REQUEST IS TO OBTAIN A CONTRACT WITH A BIOTECHNOLOGY SERVICE PROVIDER TO PERFORM A MONOCLONAL ANTIBODY (MOAB) DEVELOPMENT SERVICE	Food And Drug Administration	541720	$0	Sep 9, 2024	Sep 18, 2025
75N94020P00373 ↗	THIS AWARD IS HEREBY MODIFIED TO INCORPORATE HHSAR 352.232-71 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS IN FULL TEXT AND PROVIDE INSTRUCTIONS FOR THE TRANSITION FROM THE NIH OFFICE OF FINANCIAL MANAGEMENT (OFM) ELECTRONIC INVOICE SUBMISSION TO THE DE	National Institutes Of Health	541714	$-0	May 17, 2020	May 16, 2021
75F40120P00404 ↗	MONOCLONAL ANTIBODY PRODUCTION	Food And Drug Administration	325414	$-0	Jul 20, 2020	Jul 30, 2021
75F40122P00418 ↗	THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT.	Food And Drug Administration	325414	$-7	Aug 30, 2022	Aug 29, 2023
75N93022P01112 ↗	FY26 UDO INITIATIVE GENE SYNTHESIS AND PROTEIN PRODUCTION (AMBIS #2136137)	National Institutes Of Health	541990	$-22	Aug 30, 2022	Aug 31, 2023
75N93022P00476 ↗	FY26 UDO INITIATIVE SEQUENCING AND GENE SYNTHESIS SERVICE FOR 100 SAMPLES	National Institutes Of Health	541380	$-30	Mar 16, 2022	Mar 15, 2023
75N93021P00884 ↗	TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.	National Institutes Of Health	325413	$-30	Jun 29, 2021	Jul 1, 2021
75N93020P00483 ↗	LAW2018260 CUSTOMIZED DNA AND MONOCLONAL ANTIBODY PRODUCTION : QUOTE NO: U056VFC130	National Institutes Of Health	541714	$-31	Apr 6, 2020	May 4, 2020
75N93022P01145 ↗	FY26 UDO INITIATIVE PEPTIDE SEQUENCING SERVICE	National Institutes Of Health	541380	$-72	Sep 4, 2022	Oct 4, 2022
75N91020F00001 ↗	TO DE-OBLIGATE FY20 EXPIRING LINES PER NIH OALM COMMUNICATION 25-06 (20241105).	National Institutes Of Health	621991	$-142	Nov 17, 2019	Jan 2, 2025
75N93021P01351 ↗	FY26 UDO INITIATIVE SEQUENCING SERVICES	National Institutes Of Health	541380	$-185	Sep 12, 2021	Dec 30, 2021
75N93023P01112 ↗	FY26 UDO INITIATIVE: DNA SERVICES (GENE SYNTHESIS, VECTORARK CLONING, EXPRESS PLASMID PREPARATION) (AMBIS #2181581)	National Institutes Of Health	541380	$-195	Aug 22, 2023	Nov 29, 2023
75N93020P01044 ↗	CUSTOMIZED DNA AND MONOCLONAL ANTIBODY PRODUCTION : QUOTE NO: U150TFF080	National Institutes Of Health	325413	$-342	Aug 5, 2020	Sep 4, 2020
75N93023P01326 ↗	FY26 UDO INITIATIVE: CUSTOM GENE SYNTHESIS AND EXPRESSION	National Institutes Of Health	541380	$-500	Sep 17, 2023	Dec 30, 2023
75N93020P01205 ↗	ANTIBODY GENE SYNTHESIS AND PRODUCTION	National Institutes Of Health	541990	$-647	Aug 25, 2020	Feb 5, 2021